2014


To access this material please log in or register

Register Authorize
2014/№4

Experience of using taurine during rehabilitation of patients after cardiac surgery

Averin E.E.
State Budgetary Educational Institution of Higher Professional Education, “N.I. Pirogov Russian National Research Medical University” of the RF Ministry of Health Care, Ostrovityanova 1, Moscow 117997

Keywords: coronary bypass surgery, heart valve prosthetic replacement, taurin, CHF


DOI: 10.18087 / rhfj.2014.4.1944

Background. Increasing availability of high-tech treatments, such as cardiac surgery, heightens issues of postoperative rehabilitation. Searching for new medications and methods for successful rehabilitation of patients is a promising direction in development of reparative medicine. Aim. To determine the effect of taurine on major clinical, instrumental, laboratory, and psychological indices in patients after cardiac surgery at the rehabilitation stage. Materials and methods. The study included 48 patients with CHF aged 21 to 62 years. Groups of CHF patients receiving or not receiving taurine after a coronary bypass (CB) surgery consisted of 12 males each. Groups of CHF patients with underlying acquired valvular disease who were treated or not with taurine after the heart valve replacement also consisted of 12 patients each. Taurine (Dibicor, Limited Liability Company “PIK-FARMA”, Russia) was administered at a dose of 250 mg twice daily for three months. For all patients, clinical examination was performed; well-being, activity and mood were evaluated using the Well-Being-Activity-Mood (WBAM) Questionnaire; quality of life (QoL) was evaluated using the Minnesota Living with Heart Failure Questionnaire; ECG, EchoCG, and blood tests were performed. Results. In groups of patients treated with taurine after the heart valve prosthetic replacement and CB, LV EF was significantly increased, LV myocardial mass index was decreased, and blood triglyceride levels were decreased. The QoL significantly improved in both groups of patients treated with taurine. The WBAM Questionnaire showed that indices of well-being, activity and mood increased in groups of taurine-treated patients.
  1. ​Suleiman MS, Fernando HC, Dihmis WC et al. A loss of taurine and other amino acids from ventricles of patients undergoing bypass surgery. Br Heart J. 1993 Mar;69 (3):241–245.
  2. ​Doddakula KK, Neary PM, Wang JH et al. The antiendotoxin agent taurolidine potentially reduces ischemia / reperfusion injury through its metabolite taurine. Surgery. 2010 Sep;148 (3):567–72.
  3. Sahin MA, Yucel O, Guler A et al. Is there any cardioprotective role of Taurine during cold ischemic period ftllowing global myocardial ischemia? J Cardiothorac Surg. 2011 Mar 18;6:31.
  4. Беленков Ю. Н., Мареев В. Ю., Арутюнов Г. П., Агеев Ф. Т. Национальные рекомендации по диагностике и лечению ХСН. Журнал Сердечная недостаточность 2003;4 (6):276–297.
Averin E.E. Experience of using taurine during rehabilitation of patients after cardiac surgery. Russian Heart Failure Journal. 2014;85 (4):224–231

To access this material please log in or register

Register Authorize
Ru En